Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy.
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-for-io-in-ec/
Create your
podcast in
minutes
It is Free